nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—Localized exfoliation—Triamcinolone—multiple sclerosis	0.032	0.032	CcSEcCtD
Vildagliptin—Liver function test abnormal—Fingolimod—multiple sclerosis	0.0206	0.0206	CcSEcCtD
Vildagliptin—Infestation NOS—Fingolimod—multiple sclerosis	0.0172	0.0172	CcSEcCtD
Vildagliptin—Infestation—Fingolimod—multiple sclerosis	0.0172	0.0172	CcSEcCtD
Vildagliptin—Connective tissue disorder—Fingolimod—multiple sclerosis	0.0151	0.0151	CcSEcCtD
Vildagliptin—Angiopathy—Fingolimod—multiple sclerosis	0.014	0.014	CcSEcCtD
Vildagliptin—Blister—Prednisolone—multiple sclerosis	0.013	0.013	CcSEcCtD
Vildagliptin—Blister—Triamcinolone—multiple sclerosis	0.012	0.012	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Azathioprine—multiple sclerosis	0.0118	0.0118	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.0113	0.0113	CcSEcCtD
Vildagliptin—Infection—Fingolimod—multiple sclerosis	0.0109	0.0109	CcSEcCtD
Vildagliptin—Blister—Betamethasone—multiple sclerosis	0.0109	0.0109	CcSEcCtD
Vildagliptin—Blister—Dexamethasone—multiple sclerosis	0.0109	0.0109	CcSEcCtD
Vildagliptin—Nervous system disorder—Fingolimod—multiple sclerosis	0.0107	0.0107	CcSEcCtD
Vildagliptin—Skin disorder—Fingolimod—multiple sclerosis	0.0106	0.0106	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Cladribine—multiple sclerosis	0.0101	0.0101	CcSEcCtD
Vildagliptin—Infestation NOS—Cladribine—multiple sclerosis	0.00973	0.00973	CcSEcCtD
Vildagliptin—Infestation—Cladribine—multiple sclerosis	0.00973	0.00973	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.00945	0.00945	CcSEcCtD
Vildagliptin—Fatigue—Fingolimod—multiple sclerosis	0.00944	0.00944	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Cladribine—multiple sclerosis	0.00921	0.00921	CcSEcCtD
Vildagliptin—Pancreatitis—Azathioprine—multiple sclerosis	0.0087	0.0087	CcSEcCtD
Vildagliptin—Oedema peripheral—Cladribine—multiple sclerosis	0.00861	0.00861	CcSEcCtD
Vildagliptin—Connective tissue disorder—Cladribine—multiple sclerosis	0.00859	0.00859	CcSEcCtD
Vildagliptin—Skin exfoliation—Triamcinolone—multiple sclerosis	0.00824	0.00824	CcSEcCtD
Vildagliptin—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.00822	0.00822	CcSEcCtD
Vildagliptin—Angiopathy—Cladribine—multiple sclerosis	0.00793	0.00793	CcSEcCtD
Vildagliptin—Infestation—Azathioprine—multiple sclerosis	0.00791	0.00791	CcSEcCtD
Vildagliptin—Infestation NOS—Azathioprine—multiple sclerosis	0.00791	0.00791	CcSEcCtD
Vildagliptin—Asthenia—Fingolimod—multiple sclerosis	0.00786	0.00786	CcSEcCtD
Vildagliptin—Chills—Cladribine—multiple sclerosis	0.00784	0.00784	CcSEcCtD
Vildagliptin—Malnutrition—Cladribine—multiple sclerosis	0.00761	0.00761	CcSEcCtD
Vildagliptin—Flatulence—Cladribine—multiple sclerosis	0.00749	0.00749	CcSEcCtD
Vildagliptin—Diarrhoea—Fingolimod—multiple sclerosis	0.00749	0.00749	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Azathioprine—multiple sclerosis	0.00748	0.00748	CcSEcCtD
Vildagliptin—Skin exfoliation—Betamethasone—multiple sclerosis	0.00747	0.00747	CcSEcCtD
Vildagliptin—Skin exfoliation—Dexamethasone—multiple sclerosis	0.00747	0.00747	CcSEcCtD
Vildagliptin—Dizziness—Fingolimod—multiple sclerosis	0.00724	0.00724	CcSEcCtD
Vildagliptin—Dermatitis bullous—Prednisolone—multiple sclerosis	0.00713	0.00713	CcSEcCtD
Vildagliptin—Headache—Fingolimod—multiple sclerosis	0.00686	0.00686	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Mitoxantrone—multiple sclerosis	0.00667	0.00667	CcSEcCtD
Vildagliptin—Dermatitis bullous—Triamcinolone—multiple sclerosis	0.00655	0.00655	CcSEcCtD
Vildagliptin—Weight increased—Mitoxantrone—multiple sclerosis	0.00653	0.00653	CcSEcCtD
Vildagliptin—Skin exfoliation—Prednisone—multiple sclerosis	0.00651	0.00651	CcSEcCtD
Vildagliptin—Arthralgia—Cladribine—multiple sclerosis	0.00648	0.00648	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00643	0.00643	CcSEcCtD
Vildagliptin—Chills—Azathioprine—multiple sclerosis	0.00637	0.00637	CcSEcCtD
Vildagliptin—Oedema—Cladribine—multiple sclerosis	0.00621	0.00621	CcSEcCtD
Vildagliptin—Infection—Cladribine—multiple sclerosis	0.00617	0.00617	CcSEcCtD
Vildagliptin—Nervous system disorder—Cladribine—multiple sclerosis	0.00609	0.00609	CcSEcCtD
Vildagliptin—Skin disorder—Cladribine—multiple sclerosis	0.00603	0.00603	CcSEcCtD
Vildagliptin—Hyperhidrosis—Cladribine—multiple sclerosis	0.006	0.006	CcSEcCtD
Vildagliptin—Dermatitis bullous—Betamethasone—multiple sclerosis	0.00595	0.00595	CcSEcCtD
Vildagliptin—Dermatitis bullous—Dexamethasone—multiple sclerosis	0.00595	0.00595	CcSEcCtD
Vildagliptin—Pancreatitis—Prednisolone—multiple sclerosis	0.00577	0.00577	CcSEcCtD
Vildagliptin—Hepatitis—Mitoxantrone—multiple sclerosis	0.00574	0.00574	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.00566	0.00566	CcSEcCtD
Vildagliptin—Skin exfoliation—Methotrexate—multiple sclerosis	0.00544	0.00544	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00536	0.00536	CcSEcCtD
Vildagliptin—Weight increased—Prednisolone—multiple sclerosis	0.00536	0.00536	CcSEcCtD
Vildagliptin—Fatigue—Cladribine—multiple sclerosis	0.00535	0.00535	CcSEcCtD
Vildagliptin—Constipation—Cladribine—multiple sclerosis	0.00531	0.00531	CcSEcCtD
Vildagliptin—Pancreatitis—Triamcinolone—multiple sclerosis	0.00531	0.00531	CcSEcCtD
Vildagliptin—Pancreatitis—Methylprednisolone—multiple sclerosis	0.0053	0.0053	CcSEcCtD
Vildagliptin—Arthralgia—Azathioprine—multiple sclerosis	0.00527	0.00527	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00523	0.00523	CcSEcCtD
Vildagliptin—Chills—Mitoxantrone—multiple sclerosis	0.00515	0.00515	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Triamcinolone—multiple sclerosis	0.00503	0.00503	CcSEcCtD
Vildagliptin—Infection—Azathioprine—multiple sclerosis	0.00501	0.00501	CcSEcCtD
Vildagliptin—Urticaria—Cladribine—multiple sclerosis	0.00493	0.00493	CcSEcCtD
Vildagliptin—Weight increased—Triamcinolone—multiple sclerosis	0.00493	0.00493	CcSEcCtD
Vildagliptin—Weight increased—Methylprednisolone—multiple sclerosis	0.00492	0.00492	CcSEcCtD
Vildagliptin—Skin disorder—Azathioprine—multiple sclerosis	0.0049	0.0049	CcSEcCtD
Vildagliptin—Infestation NOS—Methylprednisolone—multiple sclerosis	0.00482	0.00482	CcSEcCtD
Vildagliptin—Infestation—Methylprednisolone—multiple sclerosis	0.00482	0.00482	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.0046	0.0046	CcSEcCtD
Vildagliptin—Weight increased—Dexamethasone—multiple sclerosis	0.00447	0.00447	CcSEcCtD
Vildagliptin—Weight increased—Betamethasone—multiple sclerosis	0.00447	0.00447	CcSEcCtD
Vildagliptin—Asthenia—Cladribine—multiple sclerosis	0.00445	0.00445	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00436	0.00436	CcSEcCtD
Vildagliptin—Arthralgia—Mitoxantrone—multiple sclerosis	0.00426	0.00426	CcSEcCtD
Vildagliptin—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.00425	0.00425	CcSEcCtD
Vildagliptin—Diarrhoea—Cladribine—multiple sclerosis	0.00425	0.00425	CcSEcCtD
Vildagliptin—Pancreatitis—Prednisone—multiple sclerosis	0.00419	0.00419	CcSEcCtD
Vildagliptin—Dizziness—Cladribine—multiple sclerosis	0.0041	0.0041	CcSEcCtD
Vildagliptin—Oedema—Mitoxantrone—multiple sclerosis	0.00408	0.00408	CcSEcCtD
Vildagliptin—Infection—Mitoxantrone—multiple sclerosis	0.00405	0.00405	CcSEcCtD
Vildagliptin—Skin disorder—Mitoxantrone—multiple sclerosis	0.00396	0.00396	CcSEcCtD
Vildagliptin—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00394	0.00394	CcSEcCtD
Vildagliptin—Angiopathy—Methylprednisolone—multiple sclerosis	0.00392	0.00392	CcSEcCtD
Vildagliptin—Weight increased—Prednisone—multiple sclerosis	0.00389	0.00389	CcSEcCtD
Vildagliptin—Headache—Cladribine—multiple sclerosis	0.00389	0.00389	CcSEcCtD
Vildagliptin—Liver function test abnormal—Methotrexate—multiple sclerosis	0.00382	0.00382	CcSEcCtD
Vildagliptin—Malnutrition—Methylprednisolone—multiple sclerosis	0.00376	0.00376	CcSEcCtD
Vildagliptin—Angioedema—Prednisolone—multiple sclerosis	0.00375	0.00375	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.00372	0.00372	CcSEcCtD
Vildagliptin—Nausea—Cladribine—multiple sclerosis	0.00369	0.00369	CcSEcCtD
Vildagliptin—Angiopathy—Betamethasone—multiple sclerosis	0.00357	0.00357	CcSEcCtD
Vildagliptin—Angiopathy—Dexamethasone—multiple sclerosis	0.00357	0.00357	CcSEcCtD
Vildagliptin—Fatigue—Mitoxantrone—multiple sclerosis	0.00352	0.00352	CcSEcCtD
Vildagliptin—Pancreatitis—Methotrexate—multiple sclerosis	0.0035	0.0035	CcSEcCtD
Vildagliptin—Constipation—Mitoxantrone—multiple sclerosis	0.00349	0.00349	CcSEcCtD
Vildagliptin—Diarrhoea—Azathioprine—multiple sclerosis	0.00345	0.00345	CcSEcCtD
Vildagliptin—Angioedema—Triamcinolone—multiple sclerosis	0.00345	0.00345	CcSEcCtD
Vildagliptin—Angioedema—Methylprednisolone—multiple sclerosis	0.00344	0.00344	CcSEcCtD
Vildagliptin—Connective tissue disorder—Prednisone—multiple sclerosis	0.00336	0.00336	CcSEcCtD
Vildagliptin—Oedema—Prednisolone—multiple sclerosis	0.00335	0.00335	CcSEcCtD
Vildagliptin—Dizziness—Azathioprine—multiple sclerosis	0.00334	0.00334	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.00332	0.00332	CcSEcCtD
Vildagliptin—Urticaria—Mitoxantrone—multiple sclerosis	0.00324	0.00324	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00324	0.00324	CcSEcCtD
Vildagliptin—Arthralgia—Methylprednisolone—multiple sclerosis	0.0032	0.0032	CcSEcCtD
Vildagliptin—Infestation NOS—Methotrexate—multiple sclerosis	0.00319	0.00319	CcSEcCtD
Vildagliptin—Infestation—Methotrexate—multiple sclerosis	0.00319	0.00319	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00318	0.00318	CcSEcCtD
Vildagliptin—Headache—Azathioprine—multiple sclerosis	0.00316	0.00316	CcSEcCtD
Vildagliptin—Angioedema—Betamethasone—multiple sclerosis	0.00313	0.00313	CcSEcCtD
Vildagliptin—Angioedema—Dexamethasone—multiple sclerosis	0.00313	0.00313	CcSEcCtD
Vildagliptin—Angiopathy—Prednisone—multiple sclerosis	0.00311	0.00311	CcSEcCtD
Vildagliptin—Oedema—Triamcinolone—multiple sclerosis	0.00308	0.00308	CcSEcCtD
Vildagliptin—Infection—Triamcinolone—multiple sclerosis	0.00306	0.00306	CcSEcCtD
Vildagliptin—Infection—Methylprednisolone—multiple sclerosis	0.00305	0.00305	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.00301	0.00301	CcSEcCtD
Vildagliptin—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00301	0.00301	CcSEcCtD
Vildagliptin—Nausea—Azathioprine—multiple sclerosis	0.003	0.003	CcSEcCtD
Vildagliptin—Skin disorder—Methylprednisolone—multiple sclerosis	0.00298	0.00298	CcSEcCtD
Vildagliptin—Malnutrition—Prednisone—multiple sclerosis	0.00298	0.00298	CcSEcCtD
Vildagliptin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00298	0.00298	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00297	0.00297	CcSEcCtD
Vildagliptin—Asthenia—Mitoxantrone—multiple sclerosis	0.00293	0.00293	CcSEcCtD
Vildagliptin—Hepatitis—Methotrexate—multiple sclerosis	0.00286	0.00286	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.0028	0.0028	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.0028	0.0028	CcSEcCtD
Vildagliptin—Oedema—Dexamethasone—multiple sclerosis	0.00279	0.00279	CcSEcCtD
Vildagliptin—Oedema—Betamethasone—multiple sclerosis	0.00279	0.00279	CcSEcCtD
Vildagliptin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00279	0.00279	CcSEcCtD
Vildagliptin—Infection—Dexamethasone—multiple sclerosis	0.00277	0.00277	CcSEcCtD
Vildagliptin—Infection—Betamethasone—multiple sclerosis	0.00277	0.00277	CcSEcCtD
Vildagliptin—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00274	0.00274	CcSEcCtD
Vildagliptin—Nervous system disorder—Betamethasone—multiple sclerosis	0.00274	0.00274	CcSEcCtD
Vildagliptin—Angioedema—Prednisone—multiple sclerosis	0.00272	0.00272	CcSEcCtD
Vildagliptin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.0027	0.0027	CcSEcCtD
Vildagliptin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.0027	0.0027	CcSEcCtD
Vildagliptin—Urticaria—Prednisolone—multiple sclerosis	0.00266	0.00266	CcSEcCtD
Vildagliptin—Fatigue—Triamcinolone—multiple sclerosis	0.00265	0.00265	CcSEcCtD
Vildagliptin—Fatigue—Methylprednisolone—multiple sclerosis	0.00265	0.00265	CcSEcCtD
Vildagliptin—Angiopathy—Methotrexate—multiple sclerosis	0.0026	0.0026	CcSEcCtD
Vildagliptin—Chills—Methotrexate—multiple sclerosis	0.00257	0.00257	CcSEcCtD
Vildagliptin—Headache—Mitoxantrone—multiple sclerosis	0.00256	0.00256	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00254	0.00254	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00254	0.00254	CcSEcCtD
Vildagliptin—Arthralgia—Prednisone—multiple sclerosis	0.00254	0.00254	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00252	0.00252	CcSEcCtD
Vildagliptin—Malnutrition—Methotrexate—multiple sclerosis	0.00249	0.00249	CcSEcCtD
Vildagliptin—Urticaria—Triamcinolone—multiple sclerosis	0.00245	0.00245	CcSEcCtD
Vildagliptin—Urticaria—Methylprednisolone—multiple sclerosis	0.00244	0.00244	CcSEcCtD
Vildagliptin—Oedema—Prednisone—multiple sclerosis	0.00243	0.00243	CcSEcCtD
Vildagliptin—Nausea—Mitoxantrone—multiple sclerosis	0.00242	0.00242	CcSEcCtD
Vildagliptin—Infection—Prednisone—multiple sclerosis	0.00242	0.00242	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00241	0.00241	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00241	0.00241	CcSEcCtD
Vildagliptin—Fatigue—Dexamethasone—multiple sclerosis	0.00241	0.00241	CcSEcCtD
Vildagliptin—Fatigue—Betamethasone—multiple sclerosis	0.00241	0.00241	CcSEcCtD
Vildagliptin—Nervous system disorder—Prednisone—multiple sclerosis	0.00239	0.00239	CcSEcCtD
Vildagliptin—Skin disorder—Prednisone—multiple sclerosis	0.00236	0.00236	CcSEcCtD
Vildagliptin—Hyperhidrosis—Prednisone—multiple sclerosis	0.00235	0.00235	CcSEcCtD
Vildagliptin—Urticaria—Dexamethasone—multiple sclerosis	0.00222	0.00222	CcSEcCtD
Vildagliptin—Urticaria—Betamethasone—multiple sclerosis	0.00222	0.00222	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00222	0.00222	CcSEcCtD
Vildagliptin—Dizziness—Prednisolone—multiple sclerosis	0.00221	0.00221	CcSEcCtD
Vildagliptin—Asthenia—Triamcinolone—multiple sclerosis	0.00221	0.00221	CcSEcCtD
Vildagliptin—Asthenia—Methylprednisolone—multiple sclerosis	0.0022	0.0022	CcSEcCtD
Vildagliptin—Arthralgia—Methotrexate—multiple sclerosis	0.00212	0.00212	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.00211	0.00211	CcSEcCtD
Vildagliptin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.0021	0.0021	CcSEcCtD
Vildagliptin—Fatigue—Prednisone—multiple sclerosis	0.0021	0.0021	CcSEcCtD
Vildagliptin—Headache—Prednisolone—multiple sclerosis	0.0021	0.0021	CcSEcCtD
Vildagliptin—Constipation—Prednisone—multiple sclerosis	0.00208	0.00208	CcSEcCtD
Vildagliptin—Dizziness—Triamcinolone—multiple sclerosis	0.00204	0.00204	CcSEcCtD
Vildagliptin—Dizziness—Methylprednisolone—multiple sclerosis	0.00203	0.00203	CcSEcCtD
Vildagliptin—Infection—Methotrexate—multiple sclerosis	0.00202	0.00202	CcSEcCtD
Vildagliptin—Asthenia—Dexamethasone—multiple sclerosis	0.002	0.002	CcSEcCtD
Vildagliptin—Asthenia—Betamethasone—multiple sclerosis	0.002	0.002	CcSEcCtD
Vildagliptin—Nervous system disorder—Methotrexate—multiple sclerosis	0.00199	0.00199	CcSEcCtD
Vildagliptin—Nausea—Prednisolone—multiple sclerosis	0.00199	0.00199	CcSEcCtD
Vildagliptin—Skin disorder—Methotrexate—multiple sclerosis	0.00197	0.00197	CcSEcCtD
Vildagliptin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00197	0.00197	CcSEcCtD
Vildagliptin—Urticaria—Prednisone—multiple sclerosis	0.00193	0.00193	CcSEcCtD
Vildagliptin—Headache—Triamcinolone—multiple sclerosis	0.00193	0.00193	CcSEcCtD
Vildagliptin—Headache—Methylprednisolone—multiple sclerosis	0.00192	0.00192	CcSEcCtD
Vildagliptin—Diarrhoea—Betamethasone—multiple sclerosis	0.00191	0.00191	CcSEcCtD
Vildagliptin—Diarrhoea—Dexamethasone—multiple sclerosis	0.00191	0.00191	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00185	0.00185	CcSEcCtD
Vildagliptin—Dizziness—Dexamethasone—multiple sclerosis	0.00185	0.00185	CcSEcCtD
Vildagliptin—Dizziness—Betamethasone—multiple sclerosis	0.00185	0.00185	CcSEcCtD
Vildagliptin—Nausea—Triamcinolone—multiple sclerosis	0.00183	0.00183	CcSEcCtD
Vildagliptin—Nausea—Methylprednisolone—multiple sclerosis	0.00182	0.00182	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.00176	0.00176	CcSEcCtD
Vildagliptin—Fatigue—Methotrexate—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Vildagliptin—Headache—Betamethasone—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Vildagliptin—Headache—Dexamethasone—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Vildagliptin—Asthenia—Prednisone—multiple sclerosis	0.00175	0.00175	CcSEcCtD
Vildagliptin—Diarrhoea—Prednisone—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Vildagliptin—Nausea—Dexamethasone—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Vildagliptin—Nausea—Betamethasone—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Vildagliptin—Urticaria—Methotrexate—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Vildagliptin—Dizziness—Prednisone—multiple sclerosis	0.00161	0.00161	CcSEcCtD
Vildagliptin—Headache—Prednisone—multiple sclerosis	0.00152	0.00152	CcSEcCtD
Vildagliptin—Asthenia—Methotrexate—multiple sclerosis	0.00146	0.00146	CcSEcCtD
Vildagliptin—Nausea—Prednisone—multiple sclerosis	0.00144	0.00144	CcSEcCtD
Vildagliptin—Diarrhoea—Methotrexate—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Vildagliptin—Dizziness—Methotrexate—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Vildagliptin—Headache—Methotrexate—multiple sclerosis	0.00127	0.00127	CcSEcCtD
Vildagliptin—Nausea—Methotrexate—multiple sclerosis	0.00121	0.00121	CcSEcCtD
